[Effect of erythromycin on intrapulmonary influx of neutrophils by intratracheal injection of lipopolysaccharide]. 1992

O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
Second Department of Internal Medicine, Nagasaki University School of Medicine.

Recently, "low dose and long term" erythromycin (EM) treatment has been reported as effective on chronic lower respiratory tract disease, including diffuse panbronchiolitis (DPB). However the effective mechanism of EM is still obscure. In this study, we investigated the effect of EM on intrapulmonary influx of neutrophils by intratracheal injection of lipopolysaccharide (LPS), and the following results were obtained. 1) The intrapulmonary influx of neutrophils was significantly suppressed (p less than 0.001) in mice intraperitoneally injected with EM at 5 mg per animal 2 hr before intratracheal injection of LPS (control group: 6.5 +/- 0.8 x 10(5) vs EM-treated group: 1.7 +/- 0.3 x 10(5)), but not 10 hr before lung challenge. This inhibition was observed at 6 hr after lung challenge, and became maximum with 84% suppression at 24 hr. 2) The intrapulmonary influx of neutrophils was not affected when EM was injected intraperitoneally daily for 3, 7, or 14 days, and lung challenge was performed 24 hr after the final administration of EM. 3) The number of neutrophils in the peripheral blood was not affected by EM. These results suggest that EM treatment impairs the capacity for pulmonary inflammation by reducing, at least in part, the migration of neutrophils to inflammatory sites.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D001988 Bronchiolitis Inflammation of the BRONCHIOLES. Bronchiolitides
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
January 1997, Nihon Kyobu Shikkan Gakkai zasshi,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
July 2004, Anesthesiology,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
January 2000, Lung,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
January 1965, Texas reports on biology and medicine,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
March 1992, The American review of respiratory disease,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
April 2007, Pflugers Archiv : European journal of physiology,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
January 1987, Journal of hygiene, epidemiology, microbiology, and immunology,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
February 1995, Antimicrobial agents and chemotherapy,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
January 2009, Folia medica Cracoviensia,
O Sakito, and J Kadota, and H Oda, and H Mukae, and A Yokoyama, and S Kawamoto, and M Kaseda, and T Morikawa, and S Kusano, and T Asai
February 1969, Arerugi = [Allergy],
Copied contents to your clipboard!